Generali Investments Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.57M Hold
189,601
0.99% 18
2026
Q1
$5.32M Buy
189,601
+46,457
+32% +$1.24M 1.24% 17
2025
Q4
$3.56M Buy
143,144
+65,552
+84% +$1.65M 0.71% 31
2025
Q3
$1.98M Buy
77,592
+21,173
+38% +$523K 0.41% 54
2025
Q2
$1.37M Buy
56,419
+31,697
+128% +$739K 0.31% 70
2025
Q1
$626K Hold
24,722
0.18% 92
2024
Q4
$656K Buy
+24,722
New +$671K 0.17% 86

Other funds holding PFE

Generali Investments Management's PFE Position: Q2 2026 in Review

Generali Investments Management held its Pfizer (PFE) position steady in Q2 2026 at 189,601 shares worth $4.57M. The position accounts for 0.99% of the portfolio, ranked #18.

Generali Investments Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.32M in Q1 2026. 631 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Generali Investments Management held 189,601 shares of Pfizer worth $4.57M as of Q2 2026.
  • Generali Investments Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.99% of Generali Investments Management's portfolio in Q2 2026, its #18 holding.
  • Generali Investments Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments Management's Pfizer position peaked at $5.32M in Q1 2026.
  • 631 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.